Publications by authors named "Peter C Trask"

Claim this Profile
A
Are changes in patient-reported outcomes prognostic for diffuse large B-Cell lymphoma survival? Results from the GOYA trial.
Jessie T Yan, Célia Bel, Peter C Trask, Ernest Lo

J Patient Rep Outcomes· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometrics of patient-reported bother from side effects of treatment single-items in industry-sponsored oncology trials.
Peter C Trask, Tracy Holt, Timothy Pearman

Qual Life Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes provide prognostic information for survival in patients with diffuse large B-cell lymphoma: Analysis of 1239 patients from the GOYA study.
Huang Huang, Asim Datye, Ming Fan, Andrea Knapp, Tina Nielsen, Peter C Trask

Cancer Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine.
Alexey V Danilov, Habte A Yimer, Michael A Boxer, John M Burke, Sunil Babu, Peter C Trask

Clin Lymphoma Myeloma Leuk· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies.
Aric Parnes, Johnny N Mahlangu, Steven W Pipe, Ido Paz-Priel, Michaela Lehle, Peter C Trask

Haemophilia· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events: Methods for item selection in industry-sponsored oncology clinical trials.
Peter C Trask, Amylou C Dueck, Elisabeth Piault, Alicyn Campbell

Clin Trials· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone.
Bruce D Cheson, Peter C Trask, John G Gribben, Natalie Dimier, Eva Kimby

Ann Hematol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.
Rachel L Police, Peter C Trask, Jianmin Wang, Robert Olivares, Shahnaz Khan

J Oncol Pharm Pract· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis.
Rachel L Police, Peter C Trask, Jianmin Wang, Robert Olivares, Shahnaz Khan

Clin Lymphoma Myeloma Leuk· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature review.
Annete Njue, Ann Colosia, Peter C Trask, Robert Olivares, Shahnaz Khan

Clin Lymphoma Myeloma Leuk· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma: a systematic literature review.
Ann Colosia, Annete Njue, Peter C Trask, Robert Olivares, Shahnaz Khan

Clin Lymphoma Myeloma Leuk· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers.
Laurel L Northouse, Darlene W Mood, Ann Schafenacker, Gregory Kalemkerian, Mark Zalupski, Peter C Trask

Psychooncology· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in chronic myeloid leukemia.
Peter C Trask, David Cella, Christine Powell, Arlene Reisman, Jennifer Whiteley

Leuk Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and prognostic indicators of response to CML treatment in a multi-country medical record review study.
Peter C Trask, Debanjali Mitra, Shrividya Iyer, Sean D Candrilli, James A Kaye

Int J Hematol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia.
Peter C Trask, David Cella, Nadine Besson, Virginia Kelly, Tamás Masszi

Leuk Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient characteristics and treatment patterns in chronic myeloid leukemia: evidence from a multi-country retrospective medical record chart review study.
Debanjali Mitra, Peter C Trask, Shrividya Iyer, Sean D Candrilli, James A Kaye

Int J Hematol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma.
Peter C Trask, Andrew G Bushmakin, Joseph C Cappelleri, Jamal Tarazi, Brad Rosbrook

J Cancer Surviv· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.
Hedy L Kindler, Tatsuya Ioka, Dirk J Richel, Jaafar Bennouna, Richard Létourneau, Peter C Trask

Lancet Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological distress in patients with pancreatic cancer--an understudied group.
Karen L Clark, Matthew Loscalzo, Peter C Trask, James Zabora, Errol J Philip

Psychooncology· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms?
Qiuling Shi, Peter C Trask, Xin Shelley Wang, Tito R Mendoza, Winifred A Apraku

J Pain Symptom Manage· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance.
Peter C Trask, Ming-Ann Hsu, Richard McQuellon

Cancer J· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
Xin Shelley Wang, Loretta A Williams, Cathy Eng, Tito R Mendoza, Nyma A Shah, Peter C Trask

Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire.
A Simon Pickard, James W Shaw, Hsiang-Wen Lin, Peter C Trask, Neil Aaronson

Value Health· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
Brian I Rini, George Wilding, Gary Hudes, Walter M Stadler, Sinil Kim, Peter C Trask

J Clin Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future perspectives on the treatment issues associated with cancer and aging.
Peter C Trask, Thomas O Blank, Paul B Jacobsen

Cancer· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis